Protective effects of melanocortins on short-term changes in a rat model of traumatic brain injury*-Reference-Cited by-同舟云学术

Protective effects of melanocortins on short-term changes in a rat model of traumatic brain injury*

Published:2012-03 Issue:3 Volume:40 Page:945-951
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Bitto Alessandra,Polito Francesca,Irrera Natasha,Calò Margherita,Spaccapelo Luca,Marini Herbert R.,Giuliani Daniela,Ottani Alessandra,Rinaldi Mariagrazia,Minutoli Letteria,Guarini Salvatore,Squadrito Francesco,Altavilla Domenica

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference18 articles.

1. The neurophysiology of brain injury

2. The profile of head injuries and traumatic brain injury deaths in Kashmir

3. Emerging treatments for traumatic brain injury

4. Clinical Trials in Traumatic Brain Injury: Lessons for the Future

5. Neuroprotective agents in traumatic brain injury

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The melanocortin receptor signaling system and its role in neuroprotection against neurodegeneration: Therapeutic insights;Annals of the New York Academy of Sciences;2023-08

2. A feasibility and safety study of afamelanotide in acute stroke patients – an open label, proof of concept, phase iia clinical trial;BMC Neurology;2023-07-26

3. Protective Effects of Melanocortins on Short-Term Changes in a Rat Model of Traumatic Brain Injury: Retraction;Critical Care Medicine;2023-02-21

4. Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice;Frontiers in Immunology;2023-01-10

5. A Feasibility and Safety Study of Afamelanotide in Acute Stroke Patients – An Open Label, Proof of Concept, Phase Iia Clinical Trial;2022-11-28